Stocks  /  NASDAQ  /  Curanex Pharmaceuticals Inc

Curanex Pharmaceuticals Inc

Industry:   Health Care – Biotechnology: Pharmaceutical Preparations

Stock Symbol:   CURXNASDAQ

 

Animal Usage:   Animal Testing

Our Opinion

https://firstwordpharma.com/story/5992717

The Company has validated Phyto-N’s effects in animal models of six inflammatory diseases: ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The primary indication is moderate to severe ulcerative colitis. The Company will advance its lead botanical drug candidate, Phyto-N, through FDA-required studies, IND submission, and into Phase I clinical trials.

Company Description

Scroll to Top